Skip to main content
. 2021 Aug 31;22(5):1235. doi: 10.3892/etm.2021.10669

Figure 2.

Figure 2

EGCG suppresses the expression of inflammatory cytokines in rats with acute glaucoma. (A) Observation of optic neuropathy by haematoxylin-eosin staining after treatment with EGCG. Magnification, x40. (B) Analysis of class III β-tubulin levels by immunofluorescence staining in the control group, model group and groups treated with EGCG for 14 and 28 days. Magnification, x40. (C) Measurement of the levels of cytokines, including IL-4, IL-6, TNF-α, IL-1β, IL-13 and IFN-γ, by flow cytometry after treatment with EGCG. *P<0.05; **P<0.01; ***P<0.001. EGCG, epigallocatechin-3-gallate; IL, interleukin; TNF, tumour necrosis factor; IFN, interferon.